ConductScience.org, home

Paper7614253

Antitat gene therapy: a candidate for late-stage AIDS patients.

Lisziewicz J and 3 others. Gene Ther, 1995. Cited by 38 papers, by iCite.

Cite this record

ConductScience Library. Antitat gene therapy: a candidate for late-stage AIDS patients. Papers, record 7614253. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7614253

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antitat gene therapy: a candidate for late-stage AIDS patients.
PubMed
Journal
Gene Ther
PubMed
Year
1995
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
38
iCite
Relative citation ratio, by iCite
0.85
iCite
Revised in PubMed
2012-11-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lisziewicz JJ
2Sun DD
3Lisziewicz AA
4Gallo RCR C

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acquired Immunodeficiency SyndromeMajor topic
CD4-Positive T-LymphocytesMajor topic
Gene Transfer TechniquesMajor topic
Genes, tatMajor topic
HIV Long Terminal RepeatMajor topic
HIV-1Major topic
CD4 Lymphocyte Count
Gene Products, tat
Genetic Therapy
Genetic Vectors
HIV Core Protein p24
HIV Infections
Humans
Leukocytes, Mononuclear
Lymphocyte Activation
RNA, Antisense
Retroviridae
Virus Replication
tat Gene Products, Human Immunodeficiency Virus

Source PubMed

Download CSV of topics

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.

PMIDTitleJournalYearIn PapersSource
11438838SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.Gene Ther2001https://conductscience.org/library/papers/11438838PubMed
10775598Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.J Virol2000https://conductscience.org/library/papers/10775598PubMed
10694813Inhibition of HIV-1 replication in chronically infected cell lines and peripheral blood mononuclear cells by retrovirus-mediated antitat gene transfer.Gene Ther2000https://conductscience.org/library/papers/10694813PubMed
10476226Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selection.Gene Ther1999https://conductscience.org/library/papers/10476226PubMed
9457428Gene therapy for infectious diseases.Clin Microbiol Rev1998https://conductscience.org/library/papers/9457428PubMed
9219238Anti-HIV ribozymes.Mol Biotechnol1997https://conductscience.org/library/papers/9219238PubMed
9217933Antisense inhibition of virus infections.Adv Pharmacol1997https://conductscience.org/library/papers/9217933PubMed
9060627Transduction of CD34+ hematopoietic progenitor cells with an antitat gene protects T-cell and macrophage progeny from AIDS virus infection.J Virol1997https://conductscience.org/library/papers/9060627PubMed
8971011Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase.J Virol1996https://conductscience.org/library/papers/8971011PubMed
8648670Targeting human immunodeficiency virus type 1 reverse transcriptase by intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle.J Virol1996https://conductscience.org/library/papers/8648670PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
TAT6898PubTator's text mininghttps://conductscience.org/library/genes/6898NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7614253

GET https://conductscience.org/api/papers/v1/7614253/authors